Trade and investment liberalization and Asia¿s noncommunicable disease epidemic: a synthesis of data and existing literature
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Trade and investment liberalization (trade liberalization) can promote or harm health. Undoubtedly it has contributed, although unevenly, to Asia's social and economic development over recent decades with resultant gains in life expectancy and living standards. In the absence of public health protections, however, it is also a significant upstream driver of non-communicable diseases (NCDs) including cardiovascular disease, cancer and diabetes through facilitating increased consumption of the 'risk commodities' tobacco, alcohol and ultra-processed foods, and by constraining access to NCD medicines. In this paper we describe the NCD burden in Asian countries, trends in risk commodity consumption and the processes by which trade liberalization has occurred in the region and contributed to these trends. We further establish pressing questions for future research on strengthening regulatory capacity to address trade liberalization impacts on risk commodity consumption and health. METHODS: A semi-structured search of scholarly databases, institutional websites and internet sources for academic and grey literature. Data for descriptive statistics were sourced from Euromonitor International, the World Bank, the World Health Organization, and the World Trade Organization. RESULTS: Consumption of tobacco, alcohol and ultra-processed foods was prevalent in the region and increasing in many countries. We find that trade liberalization can facilitate increased trade in goods, services and investments in ways that can promote risk commodity consumption, as well as constrain the available resources and capacities of governments to enact policies and programmes to mitigate such consumption. Intellectual property provisions of trade agreements may also constrain access to NCD medicines. Successive layers of the evolving global and regional trade regimes including structural adjustment, multilateral trade agreements, and preferential trade agreements have enabled transnational corporations that manufacture, market and distribute risk commodities to increasingly penetrate and promote consumption in Asian markets. CONCLUSIONS: Trade liberalization is a significant driver of the NCD epidemic in Asia. Increased participation in trade agreements requires countries to strengthen regulatory capacity to ensure adequate protections for public health. How best to achieve this through multilateral, regional and unilateral actions is a pressing question for ongoing research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moodie, R., Stuckler, D., Monteiro, C., Sheron, N., Neal, B., Thamarangsi, T., Lincoln, P., & Casswell, S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62089-3 · Cited by 1,663
The burden and costs of chronic diseases in low-income and middle-income countries.
Abegunde, D. O., Mathers, C. D., Adam, T., Ortegon, M., & Strong, K. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61696-1 · Cited by 1,603 · cited 1×
“These include ageing populations, levels of educational attainment, the characteristics of urban environments, cultural and societal norms, and the extent to which the political and policy environments are protective [16,38,39].”
BackgroundEpidemic obesity and type 2 diabetes in Asia
Yoon, K.-H., Lee, J.-H., Kim, J.-W., Cho, J. H., Choi, Y.-H., Ko, S.-H., Zimmet, P., & Son, H.-Y. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69703-1 · Cited by 1,580 · cited 1×
“Asian populations are also more likely to develop diabetes at lower levels of obesity, at younger ages, have more complications and die at younger ages [72,73].”
BackgroundPopkin, B. M. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.2.289 · Cited by 1,522 · cited 1×
“As ultra-processed foods tend to be higher in sugar, salt, saturated and trans-fats relative to unprocessed or minimally processed foods, such dietary transitions are associated with rising rates of obesity and NCDs globally [13,21,65,67-70].”
BackgroundHawkes, C. (2006) · Globalization and Health · doi:10.1186/1744-8603-2-4 · Cited by 895
Stuckler, D., McKee, M., Ebrahim, S., & Basu, S. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001235 · Cited by 666 · cited 28×
“While bilateral investment treaties (BITS) have been numerically more common, particularly so during the 1990s, today regional PTAs with investment provisions are more economically significant.”
BackgroundInfluential(2007) · Choice Reviews Online · doi:10.5860/choice.44-3398 · Cited by 550
Processed foods and the nutrition transition: evidence fromAsia
Baker, P., & Friel, S. (2014) · Obesity Reviews · doi:10.1111/obr.12174 · Cited by 276 · cited 7×
“Although consumption of processed foods and soft drinks is highest in the H-ICs, growth rates are mostly declining or stagnating in these countries (Figure 3).”
BackgroundResultInfluentialSelf-citationThe role of foreign direct investment in the nutrition transition
Hawkes, C. (2005) · Public Health Nutrition · doi:10.1079/phn2004706 · Cited by 246 · cited 2×
“This creates a difficult paradox for government regulators who must balance the opportunities for economic development these companies provide and the public health and welfare implications of those investments [20].”
BackgroundAn overview of the tobacco problem in India
Mishra, G. A., Pimple, S. A., & Shastri, S. S. (2012) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.103139 · Cited by 221
Cited by
The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing
Monteiro, C. A., Cannon, G., Moubarac, J.-C., Levy, R. B., Louzada, M. L. C., & Jaime, P. C. (2018) · Public Health Nutrition · doi:10.1017/s1368980017000234 · Cited by 2,333
Baker, P., Machado, P., Santos, T., Sievert, K., Backholer, K., Hadjikakou, M., Russell, C., Huse, O., Bell, C., Scrinis, G., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13126 · Cited by 1,194
Self-citationDefining and conceptualising the commercial determinants of health
Gilmore, A. B., Fabbri, A., Baum, F., Bertscher, A., Bondy, K., Chang, H.-J., Demaio, S., Erzse, A., Freudenberg, N., Friel, S., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00013-2 · Cited by 758
Food systems transformations, ultra-processed food markets and the nutrition transition in Asia
Baker, P., & Friel, S. (2016) · Globalization and Health · doi:10.1186/s12992-016-0223-3 · Cited by 376
Self-citationBaker, P., Smith, J., Salmon, L., Friel, S., Kent, G., Iellamo, A., Dadhich, J., & Renfrew, M. J. (2016) · Public Health Nutrition · doi:10.1017/s1368980016001117 · Cited by 175
Self-citation
Metadata
- Authors
- Baker, P., Kay, A., & Walls, H.
- Venue
- Globalization and Health
- Published
- 2014
- Volume
- 10
- Issue
- 1
- Pages
- 66
- ISSN
- 1744-8603 (ISSN-L)
- OpenAlex
- W2130552946
- Cited by
- 76
- References
- 13
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trade and investment liberalization and Asia¿s noncommunicable disease epidemic: a synthesis of data and existing literature. https://app.cochat.ai/papers/10.1186/preaccept-1893298590130414
- The paper
- Baker, P., Kay, A., & Walls, H. (2014). Trade and investment liberalization and Asia¿s noncommunicable disease epidemic: a synthesis of data and existing literature. Globalization and Health. https://doi.org/10.1186/preaccept-1893298590130414
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.